NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/10/2025
Back to search
Official data from USPTO
SYNEOS HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000087717521Class
35, 41, 42, 44
Filing
87717521
Registration
5814321
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
11/11/2025
Trademark type
Combined
Nice classes
35, 41, 42, 44
Filing date
12/12/2017
Registration date
07/23/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/10/2025
Last transaction
11/11/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/04/2018
First use in commerce
01/04/2018
Drawing code
3
Owner type
16
Owner location
MORRISVILLE, CO
Examiner
SINGLETON, RUDY
Current location
Historical data usage
Mark description
The mark consists of the term "Syneos" with the term "Health" below 'Syneos". A broken infinity symbol is in a slanted position above the letter "s" in "Syneos".
Holders and representatives
Holders
SYNEOS HEALTH, LLC
SYNEOS HEALTH, LLC
INC Research, LLC
Representatives
Michael A. Geller DLA PiperLLP (US)
Technical classification
Nice Classes
Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Strategic business consultingmarketing and advertisingpublic relations communications strategyinformation and data collection for business purposesbusiness data analyticsanalyzing business data to understand and evaluate business performanceall of the aforementioned in the pharmaceuticalbiotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment servicesadvertising clinical trialsrecruiting patientsplacing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for othersall in the pharmaceuticalbiotechnology and life sciences fields; business consulting in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalpharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; assisting pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; promoting the exchange of health information to promote patient adherence
Class 41
Education in the field of pharmaceutical salesproviding webinarsproviding live workshopsproviding on-line non-downloadable videosproviding on-line non-downloadable publications in the nature of articles and white papersproviding podcasts; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceuticalbiotechnology and life sciences fields; educational services in the field of clinical trialsproviding on-line non-downloadable videoswebinarslive workshopsproviding online non-downloadable publications in the nature of articles and white papersproviding podcasts
Class 42
Medicalscientific and data analysis research services for othersconducting and analyzing clinical trials in the pharmaceuticalbiotechnology and life sciences fields; pharmaceutical drug development servicesdeveloping clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for otherscomputerized data management of clinical trialsbiostatistical analysisenvironmental consultancypreclinical research and development evaluationrepairing flawed clinical trials and dossiersstrategic clinical research portfolio managementbiosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionalspatientsmedicalpharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet developmentdesign and consulting services for otherscreating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and diseasecreating an online community for patients and caregivers to communicate about healthcaredesign and development of interactive software for use in the communication and dissemination of medical and pharmaceutical information
Class 44
Providing medical information to physiciansother health care professionals and for medical patients; providing health information regarding the medications and health care products of othersproduct discontinuationsnew formulationsbottle changesseasonal information through e-mail alerts and push notifications
Publications
History of USPTO decisions and trademark events.
38 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/10/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/10/2025
E815
TEAS SECTION 8 & 15 RECEIVED
07/21/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/23/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/04/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/15/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/14/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/18/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/18/2019
IUAF
USE AMENDMENT FILED
05/06/2019
EISU
TEAS STATEMENT OF USE RECEIVED
05/06/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/24/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/02/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/02/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/08/2019
PUBO
PUBLISHED FOR OPPOSITION
01/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/15/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2018
GNRT
NON-FINAL ACTION E-MAILED
07/05/2018
CNRT
NON-FINAL ACTION WRITTEN
07/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/14/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/14/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/30/2018
GNRT
NON-FINAL ACTION E-MAILED
03/30/2018
CNRT
NON-FINAL ACTION WRITTEN
03/30/2018
DOCK
ASSIGNED TO EXAMINER
03/22/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/22/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/21/2017
NWAP
NEW APPLICATION ENTERED
12/15/2017
Continuous trademark protection
Get notified about every new filing that threatens SYNEOS HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.